Discover the security vulnerability in Roche medical instruments allowing attackers to execute arbitrary code. Learn about affected systems, exploitation, and mitigation steps.
A vulnerability has been detected in the Roche Accu-Chek Inform II Instrument versions prior to 03.06.00 and 04.x prior to 04.03.00, CoaguChek Pro II prior to 04.03.00, CoaguChek XS Plus prior to 03.01.06, CoaguChek XS Pro prior to 03.01.06, cobas h 232 prior to 03.01.03, and cobas h 232 prior to 04.00.04. This vulnerability involves inadequate access control to a service command, enabling attackers within the neighboring network to execute arbitrary code on the system.
Understanding CVE-2018-18563
This CVE entry describes a security vulnerability in various Roche medical instruments that could allow unauthorized code execution.
What is CVE-2018-18563?
The vulnerability in Roche medical instruments allows attackers in the adjacent network to run arbitrary code on the system through a manipulated Poct1-A message.
The Impact of CVE-2018-18563
The vulnerability poses a significant risk as it enables attackers to execute malicious code on the affected medical instruments, potentially leading to unauthorized access and control.
Technical Details of CVE-2018-18563
This section provides detailed technical information about the vulnerability.
Vulnerability Description
The vulnerability involves improper access control to a service command in Roche medical instruments, allowing attackers to execute arbitrary code.
Affected Systems and Versions
Exploitation Mechanism
Attackers within the neighboring network can exploit the vulnerability by sending a manipulated Poct1-A message to execute arbitrary code on the affected systems.
Mitigation and Prevention
It is crucial to take immediate steps to address and prevent the exploitation of this vulnerability.
Immediate Steps to Take
Long-Term Security Practices
Patching and Updates